bioRxivCell BiologyPreprint
In Troyer Syndrome Spartin loss induces Complex I impairments and alters pyruvate metabolism
Chiara Diquigiovanni, Christian Bergamini, Rebeca Diaz, Irene Liparulo, Francesca Bianco, Luca Masin, Antonia Tranchina, Francesco Buscherini, Titia Anita Wischmeijer, Tommaso PippucciiD, Emanuela Scarano, Duccio Maria Cordelli, Romana Fato, John Milton Lucocq, Marco SeriiD, Silvia Paracchini, Elena Bonora
Abstract
Growth delay and retardation are complex phenotypes which can results by a range of factors including genetics variants. We identified a novel homozygous frameshift mutation, c.892dupA, in SPART gene, in two brothers with short stature and psychomotor retardation, born from healthy consanguineous parents. Mutations in SPART are the cause of Troyer syndrome, an autosomal recessive form of spastic paraplegia resulting in muscle weakness, short stature and cognitive defects. SPART encodes for Spartin, a protein with different cellular functions, such as endosomal trafficking and mitochondrial stability.\n\nWe evaluated the effects of Spartin loss by transiently silencing SPART in human neural stem cells (hNSCs) and by generating an SH-SY5Y cell line model carrying the c.892dupA mutation via CRISPR/Cas9. In both models, we observed an altered neuronal growth and an increase in neurite outgrowth. In the SH-SY5Y cell line carrying the c.892dupA mutation, Spartin absence led to an altered distribution of mitochondria, and to a severe decrease in the NADH-dehydrogenase activity of mitochondrial Complex I. These impairments determined an energetic failure with a decrease in ATP synthesis due to a halt in mitochondrial oxidative phosphorylation, increased reactive oxygen species production, and alteration in intracellular Ca2+ homeostasis. Transient re-expression of Spartin in mutant cells restored an intracellular Ca2+ level. Mutant cells presented a significant increase in extracellular pyruvate, which may result from increased glycolysis due to impaired Complex I activity. Consistently, Spartin loss led to an over-activation of Signal Transducer and Activator of Transcription 3 (STAT3) factor, a key regulator of glycolysis.\n\nThese data demonstrate that Spartin loss leads to a profound bioenergetics imbalance with defective OXPHOS activity, and this altered metabolism might underlie Troyer syndrome and neurodevelopmental delays.
- organism: human
- assay: proteomics
- assay: metabolomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: metabolism & bioenergetics
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Troyer syndrome protein spartin mediates selective autophagy of lipid droplets
J. Chung, J. Park, … T. C. Walther·bioRxiv·Aug 18, 2021
- Rett Syndrome astrocytes disrupt neuronal activity and cerebral organoid development through transfer of dysfunctional mitochondria
Danielle L. Tomasello, M. Inmaculada Barrasa, … Rudolf Jaenisch·Scientific ReportsPeer-reviewed·Sep 4, 2024
- TECPR2 maintains mitochondrial homeostasis in neurodegeneration
Madhuri Chaurasia, Milana Fraiberg, … Zvulun Elazar·bioRxiv·Sep 4, 2025
- Loss of SPNS1, a lysosomal transporter, in the nervous system causes dysmyelination and white matter dysplasia
Yoshinobu Ichimura, Yuki Sugiura, … Masaaki Komatsu·bioRxiv·May 29, 2024
- SURF1 mutations causative of Leigh syndrome impair human neurogenesis
Gizem Inak, Agnieszka Rybak‐Wolf, … Alessandro Prigione·Nature CommunicationsPeer-reviewed·Mar 26, 2021
- A theoretical model of mitochondrial ATP synthase deficiencies. The role of mitochondrial carriers.
Jean‐Pierre Mazat, Anne Devin, … Stéphane Ransac·ProcessesPeer-reviewed·Aug 17, 2021